ONXX Related Downgrades
-
Bernstein Downgrades Onyx Pharma (ONXX) to Market Perform
-
Goldman Sachs Removes Onyx Pharmaceuticals (ONXX) from Conviction Buy List
-
Jefferies Downgrades Onyx Pharmaceuticals (ONXX) to Hold
-
Goldman Sachs Downgrades United Therapeutics Corp. (UTHR) to Neutral
-
Baird Downgrades Onyx Pharmaceuticals (ONXX) to Neutral; Nexavar Issues More Than Just Seasonality
-
Cowen Downgrades Onyx Pharma (ONXX) to Market Perform
-
BMO Capital Downgrades Onyx Pharmaceuticals (ONXX) to Market Perform
-
Caris Downgrades Onyx Pharma (ONXX) to Above Average
-
Morgan Stanley Downgrades Onyx Pharmaceuticals (ONXX) to Underweight
-
Merrill Lynch Downgrades Onyx Pharmaceuticals (ONXX) to Underperform
-
Bear Stearns downgrades Onyx Pharmaceuticals (ONXX) to Peer Perform
-
Janney Montgomery Downgrades Onyx Pharmaceuticals (ONXX) to Neutral
-
Friedman Billings downgrades Onyx Pharma (ONXX) to Underperform
-
Friedman Billings downgrades Onyx Pharma (ONXX) to Underperform
-
Leerink Swann Downgraded ONXX
-
Bear Stearns Downgraded ONXX
-
JP Morgan Downgrades ONXX; PFE competition fears
-
ONXX Coverage
-
Wachovia Securities Downgrades ONXX
-
Friedman Billings Downgrades ONXX
Back to ONXX Stock Lookup
